WuXi Biologics (Cayman) Inc.

WXIBF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$5$3$4$4
Dep. & Amort.$1$1$1$0
Deferred Tax$0$0$0-$1
Stock-Based Comp.$1$1$1$1
Change in WC-$1-$1-$1-$1
Other Non-Cash-$1-$0-$0-$0
Operating Cash Flow$5$5$6$3
Investing Activities
PP&E Inv.-$4-$4-$6-$7
Net Acquisitions$0$0-$0-$3
Inv. Purchases-$11-$15-$11-$59
Inv. Sales/Matur.$11$16$10$58
Other Inv. Act.$1$0$0$1
Investing Cash Flow-$4-$3-$6-$10
Financing Activities
Debt Repay.$0-$1-$0-$0
Stock Issued$0$0$0$11
Stock Repurch.-$2-$1-$3-$3
Dividends Paid$0$0$0$0
Other Fin. Act.-$1$4$0-$0
Financing Cash Flow-$3$2-$3$8
Forex Effect$0-$0$0-$0
Net Chg. in Cash-$1$3-$3$2
Supplemental Information
Beg. Cash$10$6$9$7
End Cash$8$10$6$9
Free Cash Flow$1$0-$0-$3
WuXi Biologics (Cayman) Inc. (WXIBF) Financial Statements & Key Stats | AlphaPilot